Skip to main content
. 2015 Apr 7;10(4):e0120709. doi: 10.1371/journal.pone.0120709

Fig 1. Effects of benfotiamine on the viability of leukemic cells.

Fig 1

BM-S and PB-R leukemic blasts (A), primary leukemia cells from six patients with AML (B), myeloid leukemia cell lines (C), malignant B cell lines (D) and T cell leukemia (E) were left untreated or treated with the indicated doses of benfotiamine and cultured for 72 hours. Cell viability was assessed using an MTT assay. The error bars represent relative cell viability with respect to the untreated control cells and are the means (SEM) of three independent experiments. (F) Growth curves of leukemia cells exposed to 50 uM of benfotiamine and analyzed at multiple time points using a colorimetric MTT assay. The average data of three independent experiments are shown.